Collections
Montana Code Annotated

Part 2

Scheduling of Dangerous Drugs

50-32-201General criteria to be considered 50-32-202Designation of drug as dangerous drug 50-32-203Effect of rescheduling under federal law 50-32-204Immediate precursors 50-32-205Nonprescription drugs not to be scheduled 50-32-206Use of names of scheduled drugs 50-32-207Order forms for drugs in Schedules I and II 50-32-208Prescription and medical requirements for scheduled drugs -- penalty 50-32-209Republication of schedules 50-32-210reserved 50-32-221Criteria for placement of drug in Schedule I 50-32-222Specific dangerous drugs included in Schedule I 50-32-223Criteria for placement of drug in Schedule II 50-32-224Specific dangerous drugs included in Schedule II 50-32-225Criteria for placement of drug in Schedule III 50-32-226Specific dangerous drugs included in Schedule III 50-32-227Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III 50-32-228Criteria for placement of drug in Schedule IV 50-32-229Specific dangerous drugs included in Schedule IV 50-32-230Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV 50-32-231Criteria for placement of drug in Schedule V 50-32-232Specific dangerous drugs included in Schedule V 50-32-233Exempt anabolic steroid products